Table 3 Baseline Characteristics for subset used for microbiome analysis, per COVID group.
Asymptomatic | Acute COVID-19 (≤ 7 days) | Ongoing symptomatic COVID-19 (28–83 days) | Post COVID-19 Syndrome (≥ 84 days) | Non-COVID-19 illness (≥ 28 days) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
n | n | n | n | n | ||||||
Total | 35 | 109 | 52 | 20 | 85 | |||||
Age (Median, IQR) | 57 | (4.75) | 57 | (4.86) | 57 | (5.67) | 53 | (3.63) | 55 | (5.42) |
Sex | ||||||||||
Male | 5 | 14% | 28 | 26% | 14 | 27% | 8 | 40% | 15 | 18% |
Female | 30 | 86% | 81 | 74% | 38 | 73% | 12 | 60% | 70 | 82% |
BMI (Median, IQR) | 24.3 | (4.75) | 24.9 | (4.86) | 24.5 | (5.67) | 26.5 | (3.63) | 24.0 | (5.42) |
